1. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA
2. Sysmex Inostics GmbH, Hamburg, Germany
3. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
5. Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
6. Moores Cancer Center, The University of California San Diego, La Jolla, CA, USA